nav-left cat-right
cat-right

Iris Pharma, RxGen Partner on Integrated Ophthalmo...

French firm Iris Pharma and RxGen have established an alliance through which they aim to provide fully integrated bench-to-bedside ophthalmology research services to the pharma and biotech industries worldwide. Iris specializes in preclinical and clinical ophthalmic contract research, while U.S.-based RxGen is a preclinical CRO focused on the development and application of translational research models. Through...

Humira Anchors Abbott’s 44% Increase in Net Income...

Abbott Laboratories is reporting a 44% year-over-year leap in net income during the first quarter. The results were propelled by Humira, which has begun its expected march to overtaking Lipitor as the world’s top-selling drug. The strong quarter prompted the company to raise its ongoing earnings-per-share outlook for 2012, during which it plans to spin off its drug development units. Abbott recorded net income...

Europe plans molecular screening center for transl...

Lucas Laursen 05 April 2012 Almost a decade ago, the US National Institutes of Health kicked off its Molecular Libraries Initiative to provide academic researchers with access to the high-throughput screening tools needed to identify new therapeutic compounds. Europe now seems keen on catching up. Last month, the Innovative Medicines Initiative (IMI), a €2 billion ($2.6 billion) Brussels-based partnership between...

Innovative screening tools accelerate drug discove...

Exclusively available in the UK from Cambio, Transcreener® HTS Assays and iuvo Microconduit array technology meet a demand for high performance tools which will speed discovery of new therapies. Dedicated to providing the pharmaceutical industry with more effective screening tools, BellBrook Labs developed the proprietary Transcreener® assays, which use no radioactive compounds. This high throughput biochemical assay...

Thermo announces its Maybridge line of bioactive m...

Thermo Fisher Scientific Inc., one of the world leaders in serving science, has announced its 50th anniversary of Maybridge line of chemistry products – a continually evolving line of bioactive molecules – for researchers to accelerate the drug discovery and development. The Maybridge line is a comprehensive range of highly innovative and diverse drug-like molecules and compound libraries for traditional drug-discovery...

Roche has extended its serology panel to include a...

With an estimated 216,000 individuals chronically infected in the UK (England 161,000, Northern Ireland 4,000, Scotland 39,000, Wales 12,000), hepatitis C (HCV) remains a major public health problem; and HCV-related end stage liver disease and mortality continue to increase1. The Health Protection Agency states that it is necessary to sustain and enhance efforts to raise awareness, prevent new infections, increase diagnosis,...
Page 20 of 61« First...10...1819202122...304050...Last »